Literature DB >> 33400042

Development of Water-Soluble Electrospun Fibers for the Oral Delivery of Cannabinoids.

Eleftherios G Andriotis1, Konstantina Chachlioutaki2, Paraskevi Kyriaki Monou2, Nikolaos Bouropoulos3,4, Dimitrios Tzetzis5, Panagiotis Barmpalexis2, Ming-Wei Chang6, Zeeshan Ahmad7, Dimitrios G Fatouros2.   

Abstract

Cannabidiol (CBD) and cannabigerol (CBG) are two active pharmaceutical ingredients, derived from cannabis plant. In the present study, CBD and CBG were formulated with polyvinyl(pyrrolidone) (PVP) and Eudragit L-100, using electrohydrodynamic atomization (electrospinning). The produced fibers were smooth and uniform in shape, with average fiber diameters in the range of 700-900 nm for PVP fibers and 1-5 μm for Eudragit L-100 fibers. The encapsulation efficiency for both CB and CBG was high (over 90%) for all formulations tested. Both in vitro release and disintegration tests of the formulations in simulated gastric fluids (SGF) and simulated intestinal fluids (SIF) indicated the rapid disintegration and dissolution of the fibers and the subsequent rapid release of the drugs. The study concluded that the electrospinning process is a fast and efficient method to produce drug-loaded fibers suitable for the per os administration of cannabinoids.

Entities:  

Keywords:  cannabidiol; cannabigerol; cannabinoids; electrospinning; nanofibers; solid dispersion

Year:  2021        PMID: 33400042     DOI: 10.1208/s12249-020-01895-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  40 in total

Review 1.  Is there any clinically relevant cannabinoid-induced analgesia?

Authors:  Birgit Kraft
Journal:  Pharmacology       Date:  2012       Impact factor: 2.547

Review 2.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

Authors:  Serena Deiana; Akihito Watanabe; Yuki Yamasaki; Naoki Amada; Marlene Arthur; Shona Fleming; Hilary Woodcock; Patricia Dorward; Barbara Pigliacampo; Steve Close; Bettina Platt; Gernot Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-07-28       Impact factor: 4.530

Review 5.  Chemical constituents of marijuana: the complex mixture of natural cannabinoids.

Authors:  Mahmoud A Elsohly; Desmond Slade
Journal:  Life Sci       Date:  2005-09-30       Impact factor: 5.037

Review 6.  Cannabidiol: State of the art and new challenges for therapeutic applications.

Authors:  Simona Pisanti; Anna Maria Malfitano; Elena Ciaglia; Anna Lamberti; Roberta Ranieri; Gaia Cuomo; Mario Abate; Giorgio Faggiana; Maria Chiara Proto; Donatella Fiore; Chiara Laezza; Maurizio Bifulco
Journal:  Pharmacol Ther       Date:  2017-02-22       Impact factor: 12.310

Review 7.  Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.

Authors:  Marika Premoli; Francesca Aria; Sara Anna Bonini; Giuseppina Maccarinelli; Alessandra Gianoncelli; Silvia Della Pina; Simone Tambaro; Maurizio Memo; Andrea Mastinu
Journal:  Life Sci       Date:  2019-03-22       Impact factor: 5.037

Review 8.  Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.

Authors:  Antonio Waldo Zuardi
Journal:  Braz J Psychiatry       Date:  2008-09       Impact factor: 2.697

9.  Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.

Authors:  Barbara Romano; Francesca Borrelli; Ester Pagano; Maria Grazia Cascio; Roger G Pertwee; Angelo A Izzo
Journal:  Phytomedicine       Date:  2013-12-25       Impact factor: 5.340

10.  Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria.

Authors:  Claes Søndergaard Wassmann; Peter Højrup; Janne Kudsk Klitgaard
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

View more
  3 in total

Review 1.  Hemp and Its Derivatives as a Universal Industrial Raw Material (with Particular Emphasis on the Polymer Industry)-A Review.

Authors:  Karol Tutek; Anna Masek
Journal:  Materials (Basel)       Date:  2022-03-31       Impact factor: 3.623

Review 2.  The Origin and Biomedical Relevance of Cannabigerol.

Authors:  Anna Jastrząb; Iwona Jarocka-Karpowicz; Elżbieta Skrzydlewska
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

3.  Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications.

Authors:  Paraskevi Kyriaki Monou; Anastasia Maria Mamaligka; Emmanuil K Tzimtzimis; Dimitrios Tzetzis; Souzan Vergkizi-Nikolakaki; Ioannis S Vizirianakis; Eleftherios G Andriotis; Georgios K Eleftheriadis; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2022-08-05       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.